Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is -9.42% vs 4.21% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 91.50% vs -67.16% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 48.08% vs 34.48% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is -61.45% vs 532.16% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Compare Quarterly Results Of Nxera Pharma Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is -32.00% vs 44.92% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -9.42% vs 4.21% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -111.27% vs 123.22% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 91.50% vs -67.16% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is -95.02% vs 1,739.93% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 48.08% vs 34.48% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 68.99% vs -95.02% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -61.45% vs 532.16% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025






